Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Running, not enrolling · Phase 2/Phase 3

Conditions studied: Alopecia Areata

In brief

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.

Key facts

Study ID
NCT03898479
Run by
Sun Pharmaceutical Industries, Inc.
People needed
1000
Starts
2019-04-04
Expected to finish
2027-06-01
Last updated by the study team
2025-10-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.